Literature DB >> 22114774

The use of multi-target drugs in the treatment of neurodegenerative diseases.

Cornelis J Van der Schyf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22114774     DOI： 10.1586/ecp.11.13

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN： 1751-2433            Impact factor:   5.045


× No keyword cloud information.
  18 in total

Review 1.  Neuroinflammation, neurodegeneration, and depression.

Authors:  Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2012-08-16       Impact factor: 3.911

2.  Synthesis and Biological Evaluation of Pentacycloundecylamines and Triquinylamines as Voltage-Gated Calcium Channel Blockers.

Authors:  Lois-May Young; Werner J Geldenhuys; Olwen C Domingo; Sarel F Malan; Cornelis J Van der Schyf
Journal:  Arch Pharm (Weinheim)       Date:  2016-02-19       Impact factor: 3.751

Review 3.  Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders.

Authors:  Dharmendra Kumar Khatri; Amey Kadbhane; Monica Patel; Shweta Nene; Srividya Atmakuri; Saurabh Srivastava; Shashi Bala Singh
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-04-08

4.  Synthesis, In Silico and Pharmacological Evaluation of New Thiazolidine-4-Carboxylic Acid Derivatives Against Ethanol-Induced Neurodegeneration and Memory Impairment.

Authors:  Shagufta Naz; Lina Tariq Al Kury; Humaira Nadeem; Fawad Ali Shah; Aman Ullah; Rehan Zafar Paracha; Muhammad Imran; Shupeng Li
Journal:  J Inflamm Res       Date:  2022-06-25

Review 5.  Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration.

Authors:  Khalid Bashir Dar; Aashiq Hussain Bhat; Shajrul Amin; Bilal Ahmad Reshi; Mohammad Afzal Zargar; Akbar Masood; Showkat Ahmad Ganie
Journal:  Cell Mol Neurobiol       Date:  2019-10-04       Impact factor: 5.046

6.  Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents.

Authors:  Sheunopa C Mzezewa; Sylvester I Omoruyi; Luke S Zondagh; Sarel F Malan; Okobi E Ekpo; Jacques Joubert
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

7.  Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study.

Authors:  Hossein Pakdaman; Koroush Gharagozli; Mehdi Abbasi; Ali Sobhanian; Ali Bakhshandehpour; Farzad Ashrafi; Mitra Khalilzad; Ali Amini Harandi
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2018-04-26

8.  The endless frontier? The recent increase of R&D productivity in pharmaceuticals.

Authors:  Fabio Pammolli; Lorenzo Righetto; Sergio Abrignani; Luca Pani; Pier Giuseppe Pelicci; Emanuele Rabosio
Journal:  J Transl Med       Date:  2020-04-09       Impact factor: 5.531

9.  GM604 regulates developmental neurogenesis pathways and the expression of genes associated with amyotrophic lateral sclerosis.

Authors:  William R Swindell; Krzysztof Bojanowski; Mark S Kindy; Raymond M W Chau; Dorothy Ko
Journal:  Transl Neurodegener       Date:  2018-12-03       Impact factor: 8.014

10.  A quantitative way to estimate clinical off-target effects for human membrane brain targets in CNS research and development.

Authors:  Athan Spiros; Hugo Geerts
Journal:  J Exp Pharmacol       Date:  2012-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.